John Sourbeer
Stock Analyst at UBS
(0)
# 4655
Out of 5,319 analysts
51
Total ratings
30.77%
Success rate
-22.37%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CYRX CryoPort | Maintains: Strong Buy | 10 11 | 5.54 | 98.56% | 6 | Apr 1, 2025 | |
STVN Stevanato Group | Maintains: Neutral | 24 24 | 21.86 | 7.5% | 2 | Mar 7, 2025 | |
QDEL QuidelOrtho | Maintains: Neutral | 43 45 | 25.17 | 78.78% | 3 | Feb 13, 2025 | |
QGEN Qiagen | Maintains: Neutral | 50 48 | 40.71 | 17.91% | 4 | Feb 7, 2025 | |
WST West Pharmaceutical ... | Upgrades: Buy | 350 390 | 201.9 | 93.16% | 3 | Dec 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 2 | 1.17 | 70.94% | 3 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 133 145 | 71.2 | 103.65% | 3 | Nov 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 15 | n/a | n/a | 2 | Mar 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 452 480 | 296.28 | 62.01% | 4 | Mar 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 8 | 1.08 | 594.44% | 2 | Mar 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 94 102 | 36.28 | 181.15% | 3 | Mar 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 58 64 | n/a | n/a | 6 | Feb 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 3 | n/a | n/a | 2 | Oct 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 50 | 7.51 | 565.78% | 1 | Feb 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 68 | n/a | n/a | 1 | Sep 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 270 | 139.32 | 93.8% | 1 | Sep 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 142 128 | 130.98 | -2.28% | 2 | Jul 27, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 13 4 | n/a | n/a | 2 | Mar 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 23 | n/a | n/a | 1 | Feb 22, 2021 |